SCHEMBL16587772

SCHEMBL16587772

Cc1nc(N2CCC(C(C)(C)C)C(C)(C)C2)ncc1C#N

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.35
JAK2 O60674 4/20 0.34
JAK1 P23458 4/20 0.34
TYK2 P29597 4/20 0.34
JAK3 P52333 4/20 0.34
KCNH2 Q12809 2/20 0.33
GPR119 Q8TDV5 2/20 0.33
KDM1A O60341 1/20 0.33
RIPK1 Q13546 2/20 0.33
CHRM2 P08172 3/20 0.32
LCAT P04180 2/20 0.32
CHRM1 P11229 2/20 0.32
KCNJ1 P48048 1/20 0.32
LRRK2 Q5S007 2/20 0.32
PIK3CD O00329 1/20 0.32
PIK3R1 P27986 1/20 0.32
CHRM4 P08173 2/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16472383 0.85 AR (0.38) ARJAK2JAK1TYK2JAK3
SCHEMBL16472307 0.81 KCNH2 (0.35) ARJAK2JAK1TYK2JAK3
SCHEMBL16587754 0.81 KCNH2 (0.35) ARJAK2JAK1TYK2JAK3
SCHEMBL16587773 0.79 GPR119 (0.39) JAK2JAK1TYK2JAK3KCNH2
SCHEMBL12683397 0.72 CHRM2 (0.42) ARJAK2JAK1TYK2JAK3
SCHEMBL16478727 0.72 CHRM2 (0.42) ARJAK2JAK1TYK2JAK3
SCHEMBL12683336 0.71 CHRM2 (0.40) ARJAK2JAK1TYK2JAK3
SCHEMBL22229899 0.71 SMN1; SMN2 (0.54) AR
SCHEMBL16472305 0.70 GPR119 (0.40) JAK2JAK1TYK2JAK3KCNH2
SCHEMBL12683565 0.69 CSNK1A1 (0.39) ARJAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987268-B2 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-24 US disclosed